NASDAQ:KNSA

Kiniksa Pharmaceuticals . Class A Stock Predictions

etoro logo Buy KNSA
*Your capital is at risk
$47.85
+0.93 (+1.98%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KNSA Prediction Chart

KNSA Predictions History

Latest community submissions for KNSA.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 28, 2025 $41.96 -1.37% $42.52 V 98.67% 2
Nov 28, 2025 $42.18 -0.86% $42.52 V 99.19% 3
Nov 28, 2025 $70.00 +64.55% $42.52 X 35.37% 0
Sep 16, 2025 $77.00 +110.61% Unrealistic Excluded from avg $35.77 X 0.00% 0
Sep 11, 2025 $75.00 +107.01% Unrealistic Excluded from avg $37.01 V 0.00% 1
Sep 10, 2025 $36.48 -1.04% $36.23 V 99.32% 4
Sep 10, 2025 $36.62 -0.65% $36.23 V 98.92% 2
Sep 10, 2025 Bearish $36.23 V 1
Sep 9, 2025 $80.00 +118.76% Unrealistic Excluded from avg $36.86 V 0.00% 1
Jul 16, 2025 $28.35 +0.91% $28.42 V 99.74% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KNSA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINIKSA PHARMACEUTICALS LTD. CLASS A
Kiniksa Pharmaceuticals . Class A
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclo...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE